As the global fight against COVID-19 continues, the emphasis on vaccine safety remains a priority. While COVID-19 vaccines from Moderna, Pfizer and J&J vaccines show higher reactogenicity than other commonly administered vaccines, SARS-CoV-2 remains a dangerous virus. Beyond the immediate threat of infection, the prolonged impact of ‘long COVID‘ is considerable. The National Center for Health Statistics (NCHS) reveals that more than 40% of U.S. adults have had a COVID-19 infection, with nearly 19% of these individuals still grappling wit…